常规超声联合超声造影评估磁共振检出的BI-RADS 4类病灶的临床价值
研究纳入171例患者的176个MRI检出BI-RADS 4类乳腺病灶,所有患者均行超声及超声造影(CEUS)检查,联合超声BI-RADS与CEUS 5点评分构建CEUS-BI-RADS。超声检出率为94.89%(167/176),联合CEUS后达100%;超声与CEUS-BI-RADS的AUC分别为0.810和0.940,CEUS-BI-RADS诊断效能显著更高(z=3.264,p=0.001),29个4类病灶降级为3类。结论认为超声联合CEUS可实现重新分类、降低活检率并有助于术前定位。
要点
- MRI检出BI-RADS 4类病灶中,超声联合CEUS的AUC为0.940,高于单用超声的0.810(p=0.001)。
- 联合CEUS后全部176个病灶均被检出,单用超声检出167个(94.89%)。
- CEUS-BI-RADS使29个(29/176)4类病灶降级为3类。
核心结论
- 超声联合CEUS可对MRI检出的BI-RADS 4类病灶进行重新分类、降低活检率,并有助于活检或手术的术前定位。
研究设计与样本
- 共纳入171例患者的176个MRI检出BI-RADS 4类乳腺病灶,所有患者均行常规超声及CEUS检查,联合超声BI-RADS与CEUS 5点评分系统构建CEUS-BI-RADS,比较超声与CEUS-BI-RADS的诊断效能,采用χ2检验比较肿块样与非肿块样强化MRI-BI-RADS 4类病灶的CEUS特征。
诊断标准与关键数值
- 超声检出率为94.89%(167/176),联合CEUS后检出率为100%;超声与CEUS-BI-RADS的ROC曲线下面积分别为0.810和0.940;CEUS-BI-RADS诊断效能显著高于单用超声(z=3.264,p=0.001);CEUS-BI-RADS将29个(29/176)4类病灶降级为3类。
临床应用与阅片要点
- 作者认为,对MRI-BI-RADS 4类病灶,超声联合CEUS是诊断价值高、临床应用前景好的方法,可实现重新分类、降低活检率并辅助术前定位。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the value of conventional ultrasound combined with contrast-enhanced ultrasound (CEUS) in Breast Imaging Reporting and Data System (BI-RADS) Category 4 lesions as detected by MRI.
METHODS: A total of 176 breast lesions from 171 patients were detected by MRI and categorised as BI-RADS 4. All patients also underwent ultrasound and CEUS scans. The combination of ultrasound-BI-RADS and CEUS 5-point scoring system created the Rerated BI-RADS (referred to as CEUS-BI-RADS). The diagnostic performances of ultrasound and CEUS-BI-RADS were then compared. A χ2 test was used to compare the CEUS features of mass-like and non-mass-like enhancement types of MRI-BI-RADS 4 lesions.
RESULTS: There were 167 (167/176) breast lesions detected by ultrasound, with a detection rate of 94.89%, while all were subsequently detected by "second-look" ultrasound combined with CEUS, with a detection rate of 100%. The areas under the receiver operating characteristic curves for ultrasound and CEUS-BI-RADS were 0.810 and 0.940, respectively. The diagnostic efficiency of CEUS-BI-RADS was significantly higher than that of ultrasound alone (z = 3.264, p = 0.001). For both mass-like and non-mass-like enhancement types of MRI-BI-RADS 4 lesions, CEUS-BI-RADS demonstrated satisfactory sensitivity and accuracy. Moreover, 29 (29/176) category 4 lesions were downgraded to 3 by CEUS-BI-RADS.
CONCLUSION: Ultrasound combined with CEUS can allow reclassification, reduce biopsy rates, and facilitate pre-surgical localisation for biopsy or surgery for MRI-BI-RADS 4 lesions.
ADVANCES IN KNOWLEDGE: For MRI-BI-RADS Category 4 lesions with a wide range of malignancies, ultrasound combined with CEUS is a promising diagnostic approach with high clinical utility.
引用
- Guo, Li, Jia, et al. The clinical value of conventional ultrasound combined with contrast-enhanced ultrasound in the evaluation of BI-RADS 4 lesions detected by magnetic resonance imaging. Br J Radiol. 2022. PMID: 35604699. doi:10.1259/bjr.20220025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。